Back
ProQR Therapeutics NV Vs. Perficient Industry Stock Comparison
Buy
53
PRQR
ProQR Therapeutics NV
Last Price:
1.94
Seasonality Move:
6.7%
Buy
69
PRFT
Perficient
Last Price:
73.61
Seasonality Move:
-0.36%
Buy
53
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.94. The Score for PRQR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Perficient (PRFT)
is a Buy
Is Perficient a Buy, Sell or Hold?
- The current Perficient [PRFT] share price is $73.63. The Score for PRFT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- PRFT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
PRFT Stock Price Chart
What is Perficient's stock price today?
-
The Perficient share price today is $73.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRFT is experiencing selling pressure, which indicates risk of future bearish movement.
PRQR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 42.28 | Sell |
Chaikin Money Flow: | -45529 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.93 - 2.01) | Sell |
Bollinger Bands (100): | (1.92 - 2.28) | Sell |
PRFT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.3 | Buy |
Relative Strength Index (14 RSI): | 78.91 | Buy |
Chaikin Money Flow: | -733734 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.95 - 70.51) | Buy |
Bollinger Bands (100): | (52.78 - 71.36) | Buy |
PRQR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.96 | Sell |
20-day SMA: | 1.98 | Sell |
50-day SMA: | 2.13 | Sell |
200-day SMA: | 1.81 | Buy |
8-day EMA: | 1.96 | Sell |
20-day EMA: | 1.99 | Sell |
50-day EMA: | 2.05 | Sell |
200-day EMA: | 1.96 | Sell |
PRFT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 73.58 | Buy |
20-day SMA: | 59.58 | Buy |
50-day SMA: | 56.67 | Buy |
200-day SMA: | 61.45 | Buy |
8-day EMA: | 71.41 | Buy |
20-day EMA: | 64.13 | Buy |
50-day EMA: | 59.99 | Buy |
200-day EMA: | 63.28 | Buy |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.25 per share.
Perficient Earnings Growth & PRFT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.04 per share, and an increase next year of $0.45 per share.
ProQR Therapeutics NV Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perficient Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |